Translational Research Symposium Speaker Spotlight: Doctor Joshua Ooi

Dr Joshua Ooi

Monash University's 5th annual Translational Research Symposium is being hosted by its three metropolitan clinical schools on 21 June 2019. The symposium will host a diverse group of medical researchers presenting their work into translational research. RSVP here.

Doctor Joshua Ooi is a senior research fellow in the Centre of Inflammatory Diseases at Monash Health.

CCS Recent Publications: 3rd - 9th April

Recent publications for Central Clinical School feature affiliated authors in the following departments:

Prof. Robyn O'Hehir AO had two articles published this week.

• Neuroscience
• MAPrc
• Peninsula Clinical School
• Anaesthesia and Perioperative Medicine
• Melbourne Sexual Health Centre
• Gastroenterology
• Australian Centre for Blood Diseases
• Diabetes
• AIRmed

Study finds drug link to harmful diabetic complication

Surgery and fasting were associated with a higher risk
of DKA in inpatients

by Anne Crawford

Diabetic ketoacidosis (DKA) is a serious and potentially life-threatening medical condition.
It is associated with very high blood glucose levels and insufficient insulin in the blood, which forces the body to burn fat for energy and leads to a build-up of dangerous chemical substances called ketones in the blood.

DKA occurs mostly in people with type 1 diabetes; those with type 2 diabetes develop it very rarely and usually in the context of severe stress.

However, in the past few years clinicians treating people with type 2 diabetes across Melbourne have noticed that some were developing the condition after being administered oral antidiabetic drugs called sodium-glucose cotransporter 2 inhibitors (SGLT2i).

A/Prof White inducted as NANOS Fellow

A/Prof Owen White, co-lead of the School's Ocular Motor Research group, has been inducted as a Fellow of the North American Neuro-Ophthalmology Society (NANOS) in recognition of his substantial contribution to NeuroOpthalmology.

Fellows must be board certified in their specialty, have a chief interest and specialty training in Neuro-Ophthalmology, be an active member of NANOS, and demonstrate special achievement in clinical NeuroOphthalmology.

A couple of photos from some recent international meetings involving CCS staff

Prof Mark Cooper AO (left) and Prof Merlin Thomas (right) in
Lebanon as part of a meeting about the Australia-Arab Grant

Prof Wendy Brown, Prof Jayashri Kulkarni
and Prof Karin Jandeleit-Dahm at a meeting
with Newcastle University in Prato recently

New recommendations for HBV during cancer therapy

Dr Joseph Doyle

Dr Joseph Doyle from the Department of Infectious Diseases was involved in the creation of Australian recommendations for the management of hepatitis B (HBV) during cancer therapy, which were released recently by the Australasian Society for Infectious Diseases.

This Australian consensus statement simplifies the approach to testing and preventive strategies for HBV during cancer therapy for medical specialists in infectious diseases, hepatology, haematology, oncology and paediatrics.

Approximately 240,000 Australians are living with hepatitis B virus infection, and approximately 2.3 million Australians have been exposed or infected in the past. Individuals with current or hepatitis B are at risk of viral reactivation during cancer therapy. Reactivation can lead to liver failure, death or cancer treatment interruption that reduces cancer survival.

Translational Research Symposium Speaker Spotlight: Associate Professor Suzanne Miller

A/Prof Suzanne Miller

Monash University's 5th annual Translational Research Symposium is being hosted by its three metropolitan clinical schools on 21 June 2019. The symposium will host a diverse group of medical researchers presenting their work into translational research. RSVP here.

Associate Professor Suzanne Miller is the Deputy Director of the Ritchie Centre at the Hudson Institute.